|
CodeMap® Compliance Briefing: April 7, 2023
Editor's Welcome:
Medicare's Molecular Diagnostics (MolDX) program was developed in 2011. Through the years there have been many changes and advancements. This week our friends at Laboratory Economics talked with Gabriel Bien-Wilner MD, PHD, chief medical officer at MolDx, regarding his work at the program and the latest updates.
Sincerely,
Lara Tavolino
Sorry, access to this content requires a current subscription.
Click here for publications catalog.
CPT copyright 2022 American Medical Association. All rights reserved.
* The responsibility for the content of any "National Correct Coding Policy" included in this product is with the Centers for Medicare and Medicaid
Services and no endorsement by the AMA is intended or should be implied. The AMA disclaims responsibility for any consequences or liability attributable to or related
to any use, nonuse, or interpretation of information contained in this product.
|
|
